Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy
Clinical trial NCT01959269 · COMPLETED
Trial details
- NCT number
- NCT01959269
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-10-31
- Primary completion
- 2017-03-31
- Enrollment
- 483
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.